Malignant Hematology and Stem Cell Transplantation Fellowship

Overview

A clinical/clinical research fellowship in malignant hematology, combined malignant hematology and hematopoietic cell transplantation, or HCT alone, tailored to the trainee.

The programme

Training type

Clinical / Clinical Research Fellowship

Duration

1-2 years

Start

July 1 (flexible)

Positions

1-2 annually

Accreditation

Institution policyUniversity of Ottawa clinical fellowship - does not lead to any Canadian (RCPSC/CFPC) certification

Department

Department of Medicine, Division of Hematology

Eligibility and visa

Eligibility

Preference for prior internal medicine and hematology training in a Canadian, British, Australian, New Zealand or US programme

International applicants

Candidates not meeting University of Ottawa training criteria must complete a PEAP before starting

Visa support

Institution policyinternational trainees need an IRCC work permit (LMIA-exempt); the uOttawa PGME/immigration advisor provides the documents needed to apply (CPSO letter of eligibility and LMIA-exemption number)

Licence requirement

Institution policyCPSO postgraduate education (educational) certificate of registration required, renewed annually; internationally trained clinical fellows must complete a 4-12 week Pre-Entry Assessment Program (PEAP); three-year licensure limit for clinical fellowships

How to apply

Deadline

Late fall (flexible)

Application method

Contact Leslie Goulding; Fellowship Director Dr. Michael Kennah

Funding

Funding

Institution policyinternational fellows without Canadian status must be funded by an official home-country sponsor (government agency or health-related charity; private funds not accepted) unless fellowship funding is available through an Ottawa hospital

Official sources